Mutagenicity of acrylonitrile (cyanoethylene) in Escherichia coli.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 339067)

Published in Mutat Res on November 01, 1977

Authors

S Venitt, C T Bushell, M Osborne

Articles by these authors

(truncated to the top 100)

High throughput analysis of differential gene expression. J Cell Biochem Suppl (1998) 11.18

Carcinogenicity and mutagenicity tests of some hair colourants and constituents. Nature (1975) 2.25

Mutagenicity of chromates in bacteria and its relevance to chromate carcinogenesis. Nature (1974) 1.98

Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet J (2001) 1.46

Changes in haemodynamic parameters following Tai Chi Chuan and aerobic exercise in patients recovering from acute myocardial infarction. Postgrad Med J (1996) 1.40

Interovulatory intervals in mares receiving deslorelin implants in Ireland (2009 to 2010). Vet Rec (2012) 1.39

Pre-operative chemo-radiotherapy in locally advanced rectal cancer: is this the way of future management? Australas Radiol (1999) 1.38

A yeast protein that binds nuclear localization signals: purification localization, and antibody inhibition of binding activity. J Cell Biol (1991) 1.24

Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis (1993) 1.15

Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis (1986) 1.11

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis (1992) 1.08

DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis (1993) 1.03

DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls. Carcinogenesis (1991) 1.03

Effects of innervation on acetylcholine sensitivity of developing muscle in vitro. J Physiol (1977) 1.03

Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med (1997) 1.02

Recommendations for the performance of bacterial mutation assays. Mutat Res (1994) 1.01

Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genet Test (1997) 1.00

The selective excision of arylalkylated products from the DNA of Escherichia coli treated with the carcinogen 7-bromomethylbenz(a)anthracene. Biochim Biophys Acta (1972) 0.99

Changing patterns and outcome of acute renal failure requiring hemodialysis. Arch Intern Med (1986) 0.98

Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis (1995) 0.98

Heterocyclic aromatic amines induce DNA strand breaks and cell transformation. Carcinogenesis (1999) 0.97

Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis (1996) 0.97

Bacterial mutagenicity tests of phenazine methosulphate and three tetrazolium salts. Mutat Res (1979) 0.95

Interstrand cross-links in the DNA of Escherichia coli B/r and Bs-1 and their removal by the resistant strain. Biochem Biophys Res Commun (1968) 0.95

The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol (R Coll Radiol) (2005) 0.93

Cowden's disease. A case report with analyses at the molecular level. Cancer (1992) 0.92

The metabolic activation of tamoxifen and alpha-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation. Carcinogenesis (1998) 0.91

Structural changes in the C-terminal region of human brain creatine kinase studied with monoclonal antibodies. Biochim Biophys Acta (1991) 0.90

Depurination of benzo[a]pyrene-diolepoxide treated DNA. Chem Biol Interact (1985) 0.90

DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis (1992) 0.90

Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Arch Neurol (1990) 0.88

Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Carcinogenesis (1994) 0.88

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat (2007) 0.88

Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol (1997) 0.87

Limited resection for breast cancer: a study of inked specimen margins before radiotherapy. Int J Radiat Oncol Biol Phys (1987) 0.87

ABC of medical computing. Storing and managing data on a computer. BMJ (1995) 0.86

Chemical transformation of Chinese hamster cells: II. Appearance of marker chromosomes in transformed cells. Br J Cancer (1976) 0.86

Bacterial mutation as an indicator of carcinogenicity. Br Med Bull (1980) 0.86

Genetic and ecological dynamics of species replacement in an arid-land river system. Mol Ecol (2005) 0.85

Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption. Lancet (1984) 0.85

Radon, mycotoxins, p53, and uranium mining. Lancet (1994) 0.85

Gaussian processes for time-series modelling. Philos Trans A Math Phys Eng Sci (2012) 0.84

Effects of alkylating agents on the induced synthesis of beta-galactosidase by Escherichia coli Bs-1. Biochim Biophys Acta (1968) 0.83

Letter: Mutagenicity of hair dyes. Lancet (1975) 0.83

Safety of prophylactic tamoxifen. Lancet (1993) 0.83

The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. J Neuroimmunol (1988) 0.82

DNA damage in breast epithelial cells: detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts. Carcinogenesis (1997) 0.82

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications. Br J Cancer (2012) 0.81

Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice. Diabetes Obes Metab (2005) 0.81

Bile acids do not form adducts when incubated with DNA in vitro. Carcinogenesis (1994) 0.81

Proceedings: Carcinogenic and mutagenic activity of chromium containing materials. Br J Cancer (1975) 0.81

Ultrastructural damage to the organ of corti during acute experimental Escherichia coli and pneumococcal meningitis in guinea pigs. Acta Otolaryngol (1996) 0.80

The DNA repair inhibitors hydroxyurea and cytosine arabinoside enhance the sensitivity of the alkaline single-cell gel electrophoresis ('comet') assay in metabolically-competent MCL-5 cells. Mutat Res (1999) 0.80

Antiproliferative effects of garlic constituents in cultured human breast-cancer cells. Oncol Rep (1995) 0.80

Effect of position and support on oral-motor skills of a child with bronchopulmonary dysplasia. Clin Pediatr (Phila) (1994) 0.80

Chromosomal damage and hair dyes. Lancet (1978) 0.80

The role of DNA cross-linking in the inactivation of bacteriophage T 7 by carcinogenic bromomethylbenz(a)-anthracenes. Biochim Biophys Acta (1972) 0.80

Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase. Mutagenesis (1993) 0.80

Genes and carcinogens. Lancet (1989) 0.79

Mutagens in human faeces. Are they relevant to cancer of the large bowel? Mutat Res (1982) 0.79

Mutagenicity of bile and duodenal adenomas in familial adenomatous polyposis. Br J Surg (1990) 0.79

Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture. Carcinogenesis (1998) 0.79

Genotoxicity of human mammary lipid. Cancer Res (1996) 0.79

Children's AIDS-related knowledge and attitudes: variations by grade, race, gender, socioeconomic status, and size of community. AIDS Educ Prev (1997) 0.79

Recurrence rates in patients with central or retroareolar breast cancers treated with mastectomy or lumpectomy. Am J Surg (2001) 0.79

Consumer input into standards revision: changing practice. J Psychiatr Ment Health Nurs (2007) 0.79

Avoidable causes of breast cancer: the known, unknown, and the suspected. Ann N Y Acad Sci (1997) 0.79

Mutagenicity and possible carcinogenicity of hair colourants and constituents. IARC Sci Publ (1976) 0.79

The bright pituitary gland--a normal MR appearance in infancy. AJNR Am J Neuroradiol (1988) 0.78

Randomized, placebo-controlled trial of gastric acid-lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis. Dis Colon Rectum (2001) 0.78

Assessing children's conceptions of AIDS. J Pediatr Psychol (1996) 0.78

A vascular hypersensitivity model of acute multifocal gastrointestinal infarction. Dig Dis Sci (1994) 0.78

Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis. Br J Surg (1998) 0.78

Differences in the levels and pattern of DNA-adduct labelling in human cell lines MCL-5 and CCRF, proficient or deficient in carcinogen-metabolism, treated in vitro with bile from familial adenomatous polyposis patients and from unaffected controls. Carcinogenesis (1996) 0.78

Expression of biomarkers for transformation in 7,12-dimethylbenz[a]anthracene-treated mammary epithelial-cells. Int J Oncol (1993) 0.77

Chromosome damage in the bone marrow of mice treated with the methylating agents methyl methanesulphonate and N-methyl-N-nitrosourea in the presence or absence of caffeine, and its relationship with thymoma induction. Mutat Res (1975) 0.77

The use of 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients. Mutat Res (1997) 0.77

N-nitrosoproline excretion in the presence and absence of gastric disease. Eur J Cancer (1991) 0.77

High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis. Gut (1995) 0.77

Mutagenicity of nitrosated alpha-amino acid derivatives N-acetyl-N'-nitrosotryptophan and its methyl ester in bacteria. Carcinogenesis (1980) 0.77

32P-postlabelling studies of target tissues and bile from patients with familial adenomatous polyposis and from unaffected controls. IARC Sci Publ (1993) 0.76

Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients. Biol Psychiatry (1982) 0.76

The development of anaerobic methods for bacterial mutation assays: aerobic and anaerobic fluctuation tests of human faecal extracts and reference mutagens. Carcinogenesis (1983) 0.76

Testing human faecal extracts for genotoxic activity with the SOS Chromotest: the importance of controlling for faecal enzyme activity. Mutagenesis (1986) 0.76

CT prior to second-look operation in ovarian cancer. AJR Am J Roentgenol (1988) 0.76

Persistent fatigue in young athletes: measuring the clinical course and identifying variables affecting clinical recovery. Scand J Med Sci Sports (2011) 0.76

The hair-dye reagent 2-(2',4'-diaminophenoxy)ethanol is mutagenic to Salmonella typhimurium. Mutat Res (1984) 0.76

Consideration of short-term carcinogenicity tests using transgenic mouse models. Mutat Res (1998) 0.75

Bile and the growth of intestinal polyps. Arch Surg (1992) 0.75

Farm quality assurance schemes. Vet Rec (1998) 0.75

A study of the heterogeneity of bacterial fluctuation-test data and the effects of auxotrophic-growth enhancement. Mutagenesis (1989) 0.75

Electrofluorescence study of polycyclic hydrocarbon diol-epoxide binding to DNA. Proc R Soc Lond B Biol Sci (1986) 0.75

"Phlebitis" and arthritis. J Ky Med Assoc (1969) 0.75

[New idea: computer in psychiatry]. Infirm Can (1971) 0.75

Short communication episodic release of steroid antibodies. J Steroid Biochem (1977) 0.75

Mutagenicity of the food colour brown FK and constituents in Salmonella typhimurium. Mutat Res (1976) 0.75

Preparation of antisera specific for 6beta-hydroxycortisol. FEBS Lett (1976) 0.75

[Intrarenal localization of tritiated angiotensin in the mesangial cells, using radioautography]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.75

Computer in psychiatry. Can Nurse (1970) 0.75

Greater omentum used for carotid cover after pharyngolaryngoesophagectomy and gastric 'pull-up' or colonic 'swing'. Arch Otolaryngol (1982) 0.75